Study to Evaluate the Efficacy of Bite's Natural Deodorant

NCT05503784 | Completed

• 1 other identifier: 20227
• Study Type: interventional
• Target: 38
• Locations: 1 country
• Sites: 1

Brief Summary

This is an open-label observational single-arm clinical trial to study the efficacy of a commercial deodorant and its effect on odor, clothing (stains), and quality of life. It is hypothesized that the deodorant marketed as Bite deodorant will mask bodily odor in participants, will not stain clothes, and improve the quality of life in trial participants.

Conditions

Sweat; Underarm Odor

Keywords

sweat; underarm odor; perspiration

Outcome Measures

Primary Outcomes (3)

• Changes in underarm odor

  Survey-based assessment (0-5 scale) of changes in underarm odor

  4 weeks

• Changes in clothing staining

  survey-based assessment (0-5 scale) of changes in clothing staining

  4 weeks

• Changes in reported quality of life

  survey-based assessment (0-5 scale) of changes in reported quality of life

  4 weeks

Study Arms (1)

Bite Deodorant

EXPERIMENTAL

All 38 participants apply BITE deodorant daily for four weeks.

Other: BITE Deodorant

Interventions

BITE Deodorant OTHER

BITE natural Deodorant

Bite Deodorant

Eligibility Criteria

• Age: 24 Years - 65 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Agree to refrain from the use of any other deodorant or antiperspirant other than Bite for the study period
• Must be in good health (does not report any medical conditions asked in the screening questionnaire)
• Must be willing to comply with the requirements of the protocol
• Must be willing to add the deodorant to their daily routine
• Is willing and able to share feedback
• Shower daily, and put deodorant on the first thing in the morning (before sweating)
• If used deodorants previously must be a natural version

You may not qualify if:

• Unwilling to follow the routine of the protocol
• Currently participating in another research study
• Severe chronic conditions including oncological conditions, psychiatric disease, or other
• Females that are pregnant, want to become pregnant for the duration of the study, or who are breastfeeding
• Presence of self-reported armpit sensitivity
• Known to have severe allergic reactions
• Have known allergies to the trial product ingredients
• Currently using an antiperspirant

Sponsors & Collaborators

• Kind Lab PBC.: lead
• Citruslabs: collaborator

Study Sites (1)

Citruslabs

Santa Monica, California, 90404, United States

Location

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Model Details: Open label

Study Record Dates

• First Submitted: August 15, 2022
• First Posted: August 17, 2022
• Study Start: November 26, 2021
• Primary Completion: March 11, 2022
• Study Completion: March 11, 2022
• Last Updated: August 17, 2022

Record last verified: 2022-08

Locations

US (1)